We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+11.8%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$804M
AUM Growth
-$172M
(-18%)
Cap. Flow
-$244M
Cap. Flow
% of AUM
-30.33%
Top 10 Holdings %
Top 10 Hldgs %
59.25%
Holding
273
New
116
Increased
49
Reduced
44
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$9.36M |
| 2 |
Assurant
AIZ
|
+$8.7M |
| 3 |
Allstate
ALL
|
+$7.12M |
| 4 |
Old Republic International
ORI
|
+$6.43M |
| 5 |
Thomson Reuters
TRI
|
+$5.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$349M |
| 2 |
Northern Trust
NTRS
|
+$10.2M |
| 3 |
T. Rowe Price
TROW
|
+$8.12M |
| 4 |
Raymond James Financial
RJF
|
+$7.49M |
| 5 |
Ameriprise Financial
AMP
|
+$6.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.57% |
| 2 | Financials | 16.5% |
| 3 | Industrials | 6.66% |
| 4 | Real Estate | 6.32% |
| 5 | Technology | 5.94% |
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2018 Portfolio in Review
As of Q1 2018, Crestline Management held 273 positions worth $804M, down 18% from $976M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Crestline Management withdrew a net $244M in Q1 2018, closing 63 positions and reducing 44 holdings. Its most notable exit was Juno Therapeutics, Inc., an estimated $349M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 38% a quarter earlier, followed by Financials and Industrials.
Against the trend, Crestline Management opened a new position in Principal Financial Group worth $8.66M.
- Crestline Management's largest Q1 2018 buy was Principal Financial Group: 142,238 shares worth $8.66M.
- Crestline Management added most to Old Republic International in Q1 2018, an estimated $6.43M increase.
- Crestline Management's biggest Q1 2018 reduction was Ameriprise Financial, cutting an estimated $6.18M.
- Crestline Management fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $349M.
- Crestline Management's ten largest holdings make up 59% of its $804M portfolio in Q1 2018.
- Crestline Management opened 116 new positions and closed 63 in Q1 2018.
- Crestline Management's portfolio value fell 18% quarter-over-quarter to $804M.
Based on Crestline Management's 13F filing for Q1 2018, filed 15 May 2018.